Search - tctmd.com

Displaying 21 - 40 of 491

Sort: Relevancy | Date

Presentation TCT 2025

TCT 733: CHA2DS2-VASc Score As a Predictor for Outcomes Following Left Atrial Appendage Closure Devices in Non-valvular Atrial Fibrillation; A Retrospective Analysis

Presenter: Joud Fahed

October 28, 2025

Presentation TCT 2025

TCT 713: Outcomes of Left Atrial Appendage Occlusion vs. Direct Oral Anticoagulants in Atrial Fibrillation: A Systematic Review and Meta-Analysis

Presenter: Zeyad Kholeif

October 27, 2025

Presentation TCT 2025

TCT 709: Oral Anticoagulation Versus Left Atrial Appendage Closure in Active Cancer Patients With Atrial Fibrillation: A Comparative Analysis of Safety and Efficacy

Presenter: Mehmet Cilingiroglu

October 27, 2025

Presentation TCT 2025

TCT 710: Plug It or Drug It? Left Atrial Appendage Occlusion vs Direct Acting oral Anticoagulants: A Propensity Matched Real World Analysis of 5-year Outcomes for patients with Atrial Fibrillation

Presenter: Pushan Aggarwal

October 27, 2025

Presentation TCT 2025

TCT 958: Impact of Baseline Anemia on Clinical Outcomes in Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention

Presenter: Ravjot Singh Bhatia

October 27, 2025

Presentation TCT 2025

TCT 706: First-in-Human Evaluation of the Zenith Left Atrial Appendage Occlusion System for Stroke Prevention in High-Risk Atrial Fibrillation Patients

Presenter: Felix Mahfoud

October 27, 2025

Presentation TCT 2025

TCT 44: Procedural Outcomes of Pulsed Field Versus Radiofrequency Ablation in Persistent Atrial Fibrillation

Presenter: Mounica Vorla

October 27, 2025

Presentation TCT 2025

TCT 399: Impact of Atrial Fibrillation on Outcomes of STEMI Patients Receiving Mechanical Circulatory Support: A National Inpatient Sample Analysis from 2016–2022

Presenter: Muhammad Majid

October 27, 2025

Presentation TCT 2025

TCT 893: Identification of Injured Myocardium in Chronic Coronary Syndromes Using Activated-Fibroblasts Imaging: A Prospective, Proof-of-Concept Study

Presenter: Shengwen Yang

October 27, 2025

Presentation TCT 2025

TCT 759: Use of Amiodarone for Prevention of New-Onset Atrial Fibrillation after Transcatheter Aortic Valve Replacement: PAF-TAVR Randomized Clinical Trial

Presenter: Gabriela Tirado-Conte

October 27, 2025

Presentation TCT 2025

TCT 581: Renal Sympathetic Denervation as Adjunctive Upstream Therapy during Atrial Fibrillation Ablation: Pooled Analysis of the HFIB and Ultra-HFIB Studies

Presenter: Vivek Y. Reddy

October 27, 2025

Presentation TCT 2025

TCT 585: Renal Denervation Combined with Atrial Fibrillation Ablation in Heart Failure: Interim 6-Month Data on Reverse Remodeling and Arrhythmia Recurrence

Presenter: Tomasz Skowerski

October 27, 2025

Presentation TCT 2025

TCT 474: Edoxaban Monotherapy for Atrial Fibrillation and Stable Coronary Artery Disease in Diabetic Patients: The EPIC-CAD Trial

Presenter: Seunghan Lee

October 27, 2025

Presentation TCT 2025

Renal Sympathetic Denervation as Adjunctive Upstream Therapy during Atrial Fibrillation Ablation: Pooled Analysis of the HFIB and Ultra-HFIB Studies

Presenter: Vivek Y. Reddy

October 27, 2025

Presentation TCT 2025

First-in-Human Evaluation of the Zenith LAAO System for Stroke Prevention in High-Risk Atrial Fibrillation Patients (AuriGen)

Presenter: Felix Mahfoud

October 26, 2025

Presentation TCT 2025

TCT 117: Contemporary Trends in Mortality and Resource Utilization in Atrial Fibrillation Versus Non-Atrial Fibrillation in Transcatheter Aortic Valve Replacement: A National Study

Presenter: Chaitanya Tumuluri

October 26, 2025

Presentation TCT 2025

Antithrombotic Therapies in ACS: Atrial Fibrillation - Triple Therapy, Triple Threat!

Presenter: Usman Baber

October 26, 2025

Presentation TCT 2025

Treatment Adherence and Adverse Events After Combined TAVR and LAAC or TAVR and Oral Anticoagulation in Patients with Atrial Fibrillation: The WATCH-TAVR OAC Compliance Study

Presenter: Grant William Reed

October 25, 2025

Presentation TCT 2025

TCT 1351: Severe Pulmonary Vein Stenosis Following Atrial Fibrillation Ablation: A Case of Successful Quadruple Pulmonary Vein Stenting

Presenter: Karolina Jasinska-Gniadzik

October 25, 2025

Presentation ESC 2025

ABC-AF study: Pragmatic registry-based randomised controlled trial of personalised treatment to reduce stroke or death in atrial fibrillation

Presenter: Jonas Oldgren

August 30, 2025

Advertisement

TCT 733: CHA2DS2-VASc Score As a Predictor for Outcomes Following Left Atrial Appendage Closure Devices in Non-valvular Atrial Fibrillation; A Retrospective Analysis

TCT 713: Outcomes of Left Atrial Appendage Occlusion vs. Direct Oral Anticoagulants in Atrial Fibrillation: A Systematic Review and Meta-Analysis

TCT 709: Oral Anticoagulation Versus Left Atrial Appendage Closure in Active Cancer Patients With Atrial Fibrillation: A Comparative Analysis of Safety and Efficacy

TCT 710: Plug It or Drug It? Left Atrial Appendage Occlusion vs Direct Acting oral Anticoagulants: A Propensity Matched Real World Analysis of 5-year Outcomes for patients with Atrial Fibrillation

TCT 958: Impact of Baseline Anemia on Clinical Outcomes in Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention

TCT 706: First-in-Human Evaluation of the Zenith Left Atrial Appendage Occlusion System for Stroke Prevention in High-Risk Atrial Fibrillation Patients

TCT 44: Procedural Outcomes of Pulsed Field Versus Radiofrequency Ablation in Persistent Atrial Fibrillation

TCT 399: Impact of Atrial Fibrillation on Outcomes of STEMI Patients Receiving Mechanical Circulatory Support: A National Inpatient Sample Analysis from 2016–2022

TCT 893: Identification of Injured Myocardium in Chronic Coronary Syndromes Using Activated-Fibroblasts Imaging: A Prospective, Proof-of-Concept Study

TCT 759: Use of Amiodarone for Prevention of New-Onset Atrial Fibrillation after Transcatheter Aortic Valve Replacement: PAF-TAVR Randomized Clinical Trial

TCT 581: Renal Sympathetic Denervation as Adjunctive Upstream Therapy during Atrial Fibrillation Ablation: Pooled Analysis of the HFIB and Ultra-HFIB Studies

TCT 585: Renal Denervation Combined with Atrial Fibrillation Ablation in Heart Failure: Interim 6-Month Data on Reverse Remodeling and Arrhythmia Recurrence

TCT 474: Edoxaban Monotherapy for Atrial Fibrillation and Stable Coronary Artery Disease in Diabetic Patients: The EPIC-CAD Trial

Renal Sympathetic Denervation as Adjunctive Upstream Therapy during Atrial Fibrillation Ablation: Pooled Analysis of the HFIB and Ultra-HFIB Studies

First-in-Human Evaluation of the Zenith LAAO System for Stroke Prevention in High-Risk Atrial Fibrillation Patients (AuriGen)

TCT 117: Contemporary Trends in Mortality and Resource Utilization in Atrial Fibrillation Versus Non-Atrial Fibrillation in Transcatheter Aortic Valve Replacement: A National Study

Antithrombotic Therapies in ACS: Atrial Fibrillation - Triple Therapy, Triple Threat!

Treatment Adherence and Adverse Events After Combined TAVR and LAAC or TAVR and Oral Anticoagulation in Patients with Atrial Fibrillation: The WATCH-TAVR OAC Compliance Study

TCT 1351: Severe Pulmonary Vein Stenosis Following Atrial Fibrillation Ablation: A Case of Successful Quadruple Pulmonary Vein Stenting

ABC-AF study: Pragmatic registry-based randomised controlled trial of personalised treatment to reduce stroke or death in atrial fibrillation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content